Lih-Wen Mau
Overview
Explore the profile of Lih-Wen Mau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Preussler J, Payton T, Moore H, Denzen E, McCann M, Mau L
Transplant Cell Ther
. 2021 Mar;
27(3):266.e1-266.e7.
PMID: 33781534
Hematopoietic cell transplantation (HCT) is a treatment for hematologic malignancies and disorders. Patients who receive HCT can face long-term physical and psychosocial effects. Survivorship care guides (care guides), which describe...
12.
Mau L, Preussler J, Burns L, Leppke S, Majhail N, Meyer C, et al.
Pharmacoeconomics
. 2020 Mar;
38(5):515-526.
PMID: 32128725
Objectives: The primary objective of this study was to predict healthcare cost trajectories for patients with newly diagnosed acute myeloid leukemia (AML) receiving allogeneic hematopoietic cell transplantation (alloHCT), as a...
13.
Dunavin N, Mau L, Meyer C, Divine C, Abdallah A, Leppke S, et al.
Biol Blood Marrow Transplant
. 2020 Jan;
26(4):805-813.
PMID: 31917269
Autologous hematopoietic stem cell transplantation (auto-HCT) is a complex procedure that can be performed in both inpatient (IP) and outpatient (OP) care settings. We examined reimbursement, service utilization, and patient...
14.
Meyer C, Mau L, Murphy E, Denzen E, Hayes E, Haven D, et al.
J Natl Compr Canc Netw
. 2019 Dec;
17(12):1473-1481.
PMID: 31805525
Background: Outcomes after hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) are better when HCT is performed during first complete remission (CR1). This study aimed to identify and address...
15.
Mau L, Meyer C, Burns L, Saber W, Steinert P, Vanness D, et al.
JNCI Cancer Spectr
. 2019 Nov;
3(4):pkz048.
PMID: 31750417
Background: The economics of allogeneic hematopoietic cell transplantation (alloHCT) for older patients with acute myeloid leukemia (AML) affects clinical practice and public policy. To assess reimbursement, utilization, and overall survival...
16.
Majhail N, Mau L, Chitphakdithai P, Denzen E, Joffe S, Lee S, et al.
Bone Marrow Transplant
. 2019 Nov;
55(5):906-917.
PMID: 31740767
Allogeneic hematopoietic cell transplantation (alloHCT) is a highly specialized procedure. We surveyed adult transplant centers in the United States (US) and then used data reported to the Center for International...
17.
Foster J, Moore H, Preussler J, Burns L, Umar J, Glotzbecker B, et al.
J Cancer Educ
. 2019 Mar;
35(4):651-660.
PMID: 30877651
Hematopoietic cell transplantation (HCT) is a complex and potentially life-threatening treatment option for patients with hematologic malignant and non-malignant diseases. Advances have made HCT a potentially curative treatment option for...
18.
Preussler J, Mau L, Majhail N, Bevans M, Clancy E, Messner C, et al.
Support Care Cancer
. 2019 Mar;
27(11):4253-4264.
PMID: 30850889
Purpose: Hematopoietic cell transplantation (HCT) often involves a long hospitalization and recovery period, with patients generally required to have a caregiver. This study aimed to identify transplant center (TC) requirements...
19.
El-Jawahri A, LeBlanc T, Burns L, Denzen E, Meyer C, Mau L, et al.
Cancer
. 2018 Oct;
124(23):4556-4566.
PMID: 30289980
Background: Despite its established benefits, palliative care (PC) is rarely utilized for hematopoietic stem cell transplant (HSCT) patients. We sought to examine transplant physicians' perceptions of PC. Methods: We conducted...
20.
Idossa L, Mau L, Ferguson S, Denzen E, Murphy E, Moore H
J Cancer Educ
. 2018 Aug;
34(5):1031-1037.
PMID: 30094780
Blood or marrow transplant (BMT) is a potentially curative treatment for numerous cancers and non-malignant disorders. BMT is a resource-intense treatment process, requiring patients to comprehend difficult health information and...